[Adrenomedullin].
Fujimoto
Shouichi
S
First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki.
Eto
Tanenao
T
D053607:Adrenomedullin; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D015415:Biomarkers; D001826:Body Fluids / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000378:metabolism; D002319:Cardiovascular System / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D005920:Glomerular Mesangium / Q000166:cytology / Q000378:metabolism; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism; D007686:Kidney Tubules, Distal / Q000378:metabolism; D009203:Myocardial Infarction / Q000188:drug therapy; D010455:Peptides / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D012079:Renal Circulation / Q000187:drug effects; D006435:Renal Dialysis; D012964:Sodium / Q000378:metabolism; D020257:Ventricular Remodeling / Q000187:drug effects
D015415:Biomarkers; D010455:Peptides; D053607:Adrenomedullin; D012964:Sodium